Merck & Co Inc logo

Merck & Co Inc

€ 90.30 (+0.78%) Aug 19
P/E:
14.05
P/B:
5.37
Market Cap:
€ 227.51B ($ 228.46B)
Enterprise V:
€ 248.67B ($ 249.71B)
Volume:
-
Avg Vol (2M):
641.00
Also Trade In:
Volume:
-
Market Cap €:
227.51B
Market Cap $:
228.46B
PE Ratio:
14.05
Avg Vol (2-Month):
641.00
Enterprise Value €:
248.67B
Enterprise Value $:
249.71B
PB Ratio:
5.37
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Merck & Co Inc
NAICS : 325412 SIC : 2834
2000 Galloping Hill Road, Kenilworth, NJ, USA, 07033
Description
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.

Financials (Next Earnings Date:2022-10-27)

FRA:6MK's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 51,390.071
EPS (TTM) (€) 5.85
Beta 0.29
Volatility % 28.66
14-Day RSI 58.93
14-Day ATR (€) 1.202442
20-Day SMA (€) 87.725
12-1 Month Momentum % 33.92
52-Week Range (€) 60.4 - 94.6
Shares Outstanding (Mil) 2,533.28

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 8
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Merck & Co Inc Filings

Document Form Filing Date
No Filing Data